IRIDEX CORP

IRIX ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $52.7M $48.7M $51.9M $57.0M $36.3M $43.4M
Cost of Revenue $33.4M $29.2M $30.1M $31.6M $20.8M $25.5M
Gross Profit $19.2M $19.5M $21.8M $25.4M $15.6M $17.9M
Gross Margin 36.5% 40.1% 42.0% 44.5% 42.8% 41.3%
Operating Expenses
Research & Development $3.7M $5.4M $6.8M $7.2M $3.3M $3.7M
SG&A Expense $7.7M $9.8M $8.7M $7.6M $6.6M $8.4M
Operating Income $-2.6M $-8.3M $-10.0M $-7.5M $-6.6M $-9.0M
Operating Margin -4.9% -17.1% -19.3% -13.2% -18.1% -20.7%
Interest Expense $58.0K $146.0K
Pretax Income $-4.4M $-8.8M $-9.5M $-7.5M $-6.3M $-8.8M
Income Tax Expense $57.0K $68.0K $90.0K $65.0K $26.0K $48.0K
Net Income $-4.4M $-8.9M $-9.6M $-7.5M $-6.3M $-8.8M
Net Margin -8.4% -18.3% -18.5% -13.2% -17.4% -20.3%
EPS (Basic) $-0.26 $-0.54 $-0.59 $-0.47 $-0.46 $-0.64
EPS (Diluted) $-0.26 $-0.54 $-0.59 $-0.47 $-0.46 $-0.64
Shares Outstanding (Basic) 16.9M 16.8M 16.4M 16.1M 15.9M 13.8M 13.8M 13.7M
Shares Outstanding (Diluted) 16.9M 16.8M 16.4M 16.1M 15.9M 13.8M 13.8M 13.7M
Dividends Per Share
← Newer Page 1 of 3 Older →